Harvard Business Review

FEBRUARY 27, 2024

The shift to advanced therapeutic modalities (ATMs) promises to change the nature of competition in the pharmaceuticals industry. They are shifting the nature of drug R&D risk and establishing manufacturing as a critical strategic priority alongside therapeutic safety and efficacy while also introducing new commercialization challenges.

Pharmaceuticals 21

Pharmaceuticals Strategy Engineering Industry 21

Great Leadership By Dan

JUNE 14, 2018

When does pharmaceutical pricing become price gouging? When does product promotion become false advertising? He has published over 170 research articles, eight books, and five edited volumes on ethics, philosophy, operations research, and cross-cultural issues, including Business Ethics as Rational Choice and Working across Cultures.

Ethics 197

Ethics Maturity Analysis Cost-Benefit Analysis 197

Strategy Driven

DECEMBER 18, 2020

Fewer people building products, packaging them, transporting them, or selling them means fewer products on the shelf. In the entertainment industry, for example, TV production has slowed, movie release dates are being pushed back, and major video game launches have been delayed as well.

Supply Chain 84

Supply Chain Retail Pharmaceuticals Technology 84

Lead Change Blog

JULY 6, 2015

This singular emphasis on results can, however, cause players to operate from an “I win, you lose” philosophy – and act to inhibit others’ performance while they maximize their own. The only output they refer to is “superior value,” which doesn’t specify their product or service. Just about everyone. Again, they are not specific.

Pharmaceuticals 150

Pharmaceuticals Discount Cooper Tactics 150

The Horizons Tracker

FEBRUARY 22, 2022

It’s a coexistent relationship that allows for considerable data to be generated that supporters believe drives productivity and allows organizations to find the optimum configuration of their facilities. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 97

Stephenson Wireless Christensen Automotive 97

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 52

Tactics Execution Pharmaceuticals Human Capital 52

HR Digest

NOVEMBER 10, 2021

Having joined the world’s largest pharmaceutical company, she is now out to raise the bar for human resources leadership across the organization. Peace, Justice and Strong Institutions: We operate to uphold justice, promote the rule of law, and develop ethical, transparent, and representative decision-making.

Diversity 102

Diversity Commitment Learning-by-Doing Globalization 102

Strategy Driven

JUNE 22, 2018

It’s a sure sign that the products or services that you are offering are quality and that you are providing customer satisfaction. When your operational and back office processes are aligned you work efficiently and productively. Here are 5 signs that you are ready to expand: 1. You have a loyal customer base. You identify gaps.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Marshall Goldsmith

NOVEMBER 4, 2013

Many leaders will be operating more like the managing director of a consulting firm. Future leaders will work with their managers in a team approach that combines the leader’s knowledge of unit operations with the manager’s understanding of larger needs. The same trend is occurring in pharmaceuticals and telecommunications.

Short-term 107

Short-term Long-term Trends Telecommunications 107

Strategy Driven

JULY 13, 2011

They might include sales productivity metrics such as market share, the company’s ability to charge premium prices relative to peers, or sales force productivity. Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

DECEMBER 23, 2016

When partners in an alliance come into conflict, it can be just what is needed to produce a technically and commercially successful product. ” Members from each partner organization rate the alliance in areas related to strategic fit, operational fit, and cultural fit. The results were fascinating.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. And what can we learn from it? Commercial.

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. And so pharmaceutical firms appear to be benefitting from regulators’ incomplete decision process.

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. In the process, I came up with six rules that could also help others change their cultures.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. If so, then high profits portend diminished productivity growth. In a new research paper , I tease apart the factors associated with the growth in corporate valuations relative to assets ( Tobin’s Q ) and the growth in operating margins.

Pharmaceuticals 11

Pharmaceuticals Politics Price Chemicals 11

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Strategy Driven

MARCH 18, 2011

PL and CM: Coherent companies – those that possess a capabilities system that aligns their strategy with their product/service portfolio – generate superior performance over time, which is what we call the coherence premium. SD : What is the ‘coherence premium?’. SD : What does it mean to have a ‘right to win?’.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

NOVEMBER 29, 2018

In this article, I’d like to share the insights we’ve gleaned from the model’s first full year of operation, which hopefully organizations in health care and many other industries will find useful. On the business side, the escalation process has provided improved visibility into operations.

Health Care 11

Health Care System Metrics Report 11

Harvard Business Review

AUGUST 14, 2018

Many leading American digital firms, including Google, Amazon, eBay, and Uber, have successfully expanded internationally by introducing their products, services, and platforms in other countries. failure to fully embed operations in China. Uber sold its operation to Didi Chuxing. Paper Boat Creative/Getty Images.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

SEPTEMBER 21, 2018

This isn’t all that surprising given the level of innovation activity in these sectors, but directors operating in similarly disrupted sectors should take note. Just over one-fifth (22%) of boards operating in the IT and telecom industry sought tech expertise when filling their most recent board seat, higher than in any other industry.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

FEBRUARY 29, 2016

For example, it increased both the number and status of safety personnel, and it strengthened safety operating procedures. We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. But learning waned as avoiding launch delays became increasingly important.

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Mortgages exist to spread the costs of a home or a car out over a longer period of time, thereby allowing people to buy a product that they otherwise could not afford.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Productivity can help; but it is not enough to achieve superstardom. The link between superstar firms, sectors, and cities is complex.

Industry 13

Industry Company GDP Bottom-up 13

Harvard Business Review

MARCH 11, 2013

Yes, Apple is obviously super-secretive with its customers about product announcements. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. They have few details about what is in the company's product pipeline.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Imports among the world’s 20 largest economies have fallen as a share of their gross domestic product for four consecutive years. at the forefront.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

NOVEMBER 24, 2015

The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations. Economies of scale in production are often limited to the factory level; that is, they come from larger factories, not necessarily from larger firms.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

OCTOBER 26, 2017

Nowadays, when a multitude of businesses are confronted with the leap from “dumb” products to creating smart, connected ones , and cities and regions are trying to make the leap from manufacturing to services, relying too heavily on past successes will only lock those clusters in the past.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

MARCH 21, 2018

Looking ahead, we will continue to drive productivity, and we plan to conduct a deep dive into the details of our cost structure and allocation of capital to ensure we deliver appropriate returns for shareholders.” Injuries and catastrophic events, in addition to being tragic, are evidence that production is not being managed correctly.

Operations 17

Operations Chemicals CEO Metrics 17

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Recognizing this, Sun began to work more closely with Fujitsu and Texas Instruments.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. What happens, for example, if the value of a product’s underlying intellectual property overtakes its production value?

Supply Chain 8

Supply Chain Execution Analysis Technology 8